Literature DB >> 2226518

Macrophage uptake of cholesterol-containing particles derived from LDL and isolated from atherosclerotic lesions.

H F Hoff1, J O'Neil, J M Pepin, T B Cole.   

Abstract

A variety of different cholesterol-rich particles with different physical and chemical structures can be isolated from human atherosclerotic lesions. Many of these particles are internalized in an unregulated fashion by macrophages in culture, leading to lipid loading of these cells. However, the in vivo relevance of this uptake is still uncertain. In this overview, we have summarized data obtained primarily in our laboratory on low density lipoprotein (LDL)-like particles (A-LDL) and large cholesterol-rich droplets isolated from human atherosclerotic lesions. Based on our studies, we propose a variety of different mechanisms of uptake. A-LDL can be internalized by the LDL receptor or the scavenger receptor on macrophages in culture; the latter uptake mechanism can lead to lipid loading. In addition, at high concentrations A-LDL can undergo aggregation, possibly due to intermolecular cross-bridging by aldehydes released during oxidation of these particles. The aggregates are subsequently internalized by macrophages by phagocytosis, a process which appears to be independent of the LDL or scavenger receptor. By contrast, arterial smooth muscle cells do not take up these aggregates. Large cholesteryl ester-rich particles isolated from human lesions, and derived from LDL that had been degraded by hydrolytic enzymes in the extracellular space of the arterial wall, or from inclusions released from lysed foam cells, are also internalized via phagocytosis by macrophages in culture. Since some of these particles contain apoliproteins and/or proteins that are ligands for receptors on macrophages, initial receptor-mediated binding may precede and facilitate subsequent phagocytosis in some cases. Uptake of the diverse group of cholesteryl ester-rich particles in plaques can induce lipid loading of macrophages and therefore may lead to further growth of the atherosclerotic plaque.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226518     DOI: 10.1093/eurheartj/11.suppl_e.105

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

1.  Xanthoma tissue-extracted LDL density substances are the main inducer of myelin-like bodies and ceroid granules in foam cells.

Authors:  Kimiko Nakajima; Mitsunori Ikeda; Ken-Ichi Yagyu; Hideki Nakajima; Masaaki Matsumoto; Masahiro Seike; Hajime Kodama
Journal:  Med Mol Morphol       Date:  2007-03-29       Impact factor: 2.309

2.  Size-selective uptake of colloidal low density lipoprotein aggregates by cultured white blood cells.

Authors:  Michael J Walters; Steven P Wrenn
Journal:  J Colloid Interface Sci       Date:  2010-07-03       Impact factor: 8.128

3.  Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.

Authors:  S L Schissel; J Tweedie-Hardman; J H Rapp; G Graham; K J Williams; I Tabas
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

4.  Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.

Authors:  L Lindstedt; M Lee; G R Castro; J C Fruchart; P T Kovanen
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

5.  Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.

Authors:  Takhar Kasumov; Ling Li; Min Li; Kailash Gulshan; John P Kirwan; Xiuli Liu; Stephen Previs; Belinda Willard; Jonathan D Smith; Arthur McCullough
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 6.  Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism.

Authors:  Joshua A Dubland; Gordon A Francis
Journal:  Front Cell Dev Biol       Date:  2015-02-02

7.  On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety.

Authors:  S Bhakdi; B Dorweiler; R Kirchmann; J Torzewski; E Weise; J Tranum-Jensen; I Walev; E Wieland
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

Review 8.  The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans.

Authors:  Jan Borén; Chris J Packard; Marja-Riitta Taskinen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-28       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.